In vivo spectroscopy pf the ovary at 3 Tesla

Purpose: The goal is to improve screening for ovarian cancer preoperatively by non-invasively confirming or excluding malignancy of a suspicious pelvic mass and, if malignant, determining extent of disease by using chemical shift magnetic resonance imaging at 3T. The spectral alterations associated with ovarian pathology on biopsy are already established (1). Methods: Patients were recruited from those presenting with primary ovarian neoplasms to the Gynaecological Oncology Unit at Royal North Shore and Royal Prince Alfred Hospitals in Sydney. In vivo MR data was collected on a commercially available whole-body…